本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Apimeds Pharmaceutical U.S, Inc.

1.74
-0.0300-1.69%
成交量:1.48万
成交额:2.67万
市值:2,014.22万
市盈率:-9.19
高:1.84
开:1.80
低:1.73
收:1.77
数据加载中...
2025/06/05

重要事件披露

Form 8-K - Current report
2025/05/23

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/05/20

重要事件披露

Form 8-K - Current report
2025/05/20

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/12

重要事件披露

Form 8-K - Current report
2025/05/02

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2025/04/15

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/04/15

重要事件披露

Form 8-K - Current report
2025/02/10

SEC问询函

Form CORRESP - Correspondence
2025/02/10

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2025/02/10

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/02/08

SEC问询函

Form CORRESP - Correspondence
2025/02/08

SEC问询函

Form CORRESP - Correspondence
2025/02/06

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/01/29

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/01/10

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/12/20

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/12/20

SEC问询函

Form CORRESP - Correspondence
2024/12/09

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/11/08

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]